Angiogenesis is obligatory for the genesis and progression of solid cancers and is a logical target for cancer chemoprevention. This grant application will test the hypothesis that methylselenol or related monomethylselenium metabolites inhibit vascular endothelial angiogenic responses by multiple processes: a) inhibiting mitogenic signaling leading to G1 cell cycle arrest; b) inducing apoptosis through caspase-driven execution; c) inhibiting the expression of matrix metalloproteinase (MMP)-2 that is required for degrading tissue matrix. We will 1) investigate the mediator role of a methylselenium-inhibition of the phosphatidylinositol 3- kinase (PI3K) signaling cascade in vascular cell G1 arrest using biochemical, kinase pharmacologic inhibitor and active kinase mutant transfection approaches; 2) define the pathways through which methy-seLenium induces vascular endothelial cell apoptosis, especially what caspases are activated and any role of the mitochondria and cytochrome C in their activation as well as whether PI3K and/or mitogenic activated protein kinase (MAPKJERK1/2) inhibition mediate apoptosis signaling; 3) define what stage(s) of MMP-2 expression is targeted by methylselenium and elucidate the biochemical/molecular mechanisms involved. In particular, we will test whether methylselenol disrupts disulfide bonds in MMP-2 and model protein/peptide molecules. Human umbilical vein endothelial cells and their telomerized immortal clones will be used in cell culture models to accomplish these aims. By accomplishing the first 2 aims, we expect to validate a mediator role of PI3K and/or MAPK1/2 pathways for methylselenium inhibition of endothelial cell cycling as well as for apoptosis signaling leading to caspase-driven execution. This can lay the foundation for future work to investigate how methylselenium reacts/interacts with these target proteins to bring about the biochemical and cellular effects. In addition, elucidating the mechanisms of MMP-2 expression regulation in Aim 3 and especially disulfide disruption as a potential cause of its degradation may have broader mechanistic implications for inhibiting autocrine/paracrine-mediated tumor angiogenesis, growth, survival and invasiveness by selenium. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA092231-02
Application #
6702564
Study Section
Special Emphasis Panel (ZRG1-PTHB (02))
Program Officer
Perloff, Marjorie
Project Start
2003-03-01
Project End
2007-02-28
Budget Start
2004-03-01
Budget End
2005-02-28
Support Year
2
Fiscal Year
2004
Total Cost
$267,000
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Organized Research Units
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Hu, Hongbo; Li, Guang-Xun; Wang, Lei et al. (2008) Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin. Clin Cancer Res 14:1150-8
Lee, Hyo Jeong; Lee, Hyo-Jung; Song, Gyu-Yong et al. (2007) 6-(1-Oxobutyl)-5,8-dimethoxy-1,4-naphthoquinone inhibits lewis lung cancer by antiangiogenesis and apoptosis. Int J Cancer 120:2481-90
Hu, Hongbo; Jiang, Cheng; Schuster, Todd et al. (2006) Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway. Mol Cancer Ther 5:1873-82
Hu, Hongbo; Jiang, Cheng; Li, Guangxun et al. (2005) PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells. Carcinogenesis 26:1374-81
Hu, Hongbo; Jiang, Cheng; Ip, Clement et al. (2005) Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells. Clin Cancer Res 11:2379-88
Cho, Sung Dae; Jiang, Cheng; Malewicz, Barbara et al. (2004) Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription. Mol Cancer Ther 3:605-11
Jiang, Cheng; Kim, Ki-Hwan; Wang, Zaisen et al. (2004) Methyl selenium-induced vascular endothelial apoptosis is executed by caspases and principally mediated by p38 MAPK pathway. Nutr Cancer 49:174-83
Jiang, Cheng; Hu, Hongbo; Malewicz, Barbara et al. (2004) Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells. Mol Cancer Ther 3:877-84